RØYRVIK ET AL.A<strong>no</strong>ther topic that deserves attention is the functional consequence of mutatio<strong>no</strong>f mutated target gene expression. Both on the transcriptomic <strong>and</strong> proteomiclevels, a large-scale approach to this area would be useful <strong>in</strong> underst<strong>and</strong><strong>in</strong>g therole of MSI <strong>in</strong> oncogenesis.Consider<strong>in</strong>g the comparative wealth of untested putative MMR target genesamong cMNR-conta<strong>in</strong><strong>in</strong>g sequences alone, <strong>no</strong>t to mention those harbor<strong>in</strong>g di<strong>and</strong>tr<strong>in</strong>ucleotide or repeats <strong>in</strong> UTRs <strong>and</strong> <strong>in</strong>trons, it seems clear that a highthroughputapproach to analysis is desirable. Ideally, if somewhat unrealistically,all potential targets—both those that have been assessed <strong>in</strong> MSI tumors <strong>and</strong> thosethat have <strong>no</strong>t—should be evaluated for a large consecutive cl<strong>in</strong>ical series.In short, after 12 years of <strong>research</strong> <strong>in</strong>to targeted genes of mismatch repair deficientcolorectal cancers, we believe that those identified scarcely constituteeven the tip of the iceberg.REFERENCES1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics,2006. CA Cancer J Cl<strong>in</strong>. 2006;56:106–30.2. Radtke F, Clevers H. Self-renewal <strong>and</strong> cancer of the gut: two sides of a co<strong>in</strong>.Science. 2005;307(5717):1904–9.3. Fearon ER, Vogelste<strong>in</strong> B. A <strong>genetic</strong> model for colorectal tumorigenesis. Cell.1990;61:759–67.4. Grady WM. Ge<strong>no</strong>mic <strong>in</strong>stability <strong>and</strong> colon cancer. Cancer Metastasis Rev.2004;23:11–27.5. Nowell PC. The clonal evolution of tumor cell populations. Science. 1976;194(4260):23–8.6. Lengauer C, K<strong>in</strong>zler KW, Vogelste<strong>in</strong> B. Genetic <strong>in</strong>stabilities <strong>in</strong> human cancers.Nature. 1998;396(6712):643–9.7. Bol<strong>and</strong> CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, BurtRW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S. ANational Cancer Institute workshop on microsatellite <strong>in</strong>stability for cancer detection<strong>and</strong> familial predisposition: development of <strong>in</strong>ternational criteria for thedeterm<strong>in</strong>ation of microsatellite <strong>in</strong>stability <strong>in</strong> colorectal cancer. Cancer Res.1998;58:5248–57.8. Lengauer C, K<strong>in</strong>zler KW, Vogelste<strong>in</strong> B. Genetic <strong>in</strong>stability <strong>in</strong> colorectal cancers.Nature. 1997;386(6625):623–7.9. Rajagopalan H, Nowak MA, Vogelste<strong>in</strong> B, Lengauer C. The significance ofunstable chromosomes <strong>in</strong> colorectal cancer. Nat Rev Cancer. 2003;3:695–701.242
TARGET GENES OF MSI COLORECTAL CANCER10. Thibodeau SN, Bren G, Schaid D. Microsatellite <strong>in</strong>stability <strong>in</strong> cancer of theproximal colon. Science. 1993;260(5109):816–9.11. Duval A, Hamel<strong>in</strong> R. Genetic <strong>in</strong>stability <strong>in</strong> human mismatch repair deficientcancers. Ann Genet. 2002;45:71–5.12. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Meckl<strong>in</strong> JP,Jarv<strong>in</strong>en H, Powell SM, Jen J, Hamilton SR, . Clues to the pathogenesis of familialcolorectal cancer. Science. 1993;260(5109):812–6.13. Lothe RA, Peltomaki P, Mel<strong>in</strong>g GI, Aaltonen LA, Nystrom-Lahti M, PylkkanenL, Heimdal K, Andersen TI, Moller P, Rognum TO, . Ge<strong>no</strong>mic <strong>in</strong>stability<strong>in</strong> colorectal cancer: relationship to cl<strong>in</strong>icopathological variables <strong>and</strong> familyhistory. Cancer Res. 1993;53:5849–52.14. Io<strong>no</strong>v Y, Pe<strong>in</strong>ado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somaticmutations <strong>in</strong> simple repeated sequences reveal a new mechanism forcolonic carc<strong>in</strong>ogenesis. Nature. 1993;363(6429):558–61.15. Bubb VJ, Curtis LJ, Cunn<strong>in</strong>gham C, Dunlop MG, Carothers AD, Morris RG,White S, Bird CC, Wyllie AH. Microsatellite <strong>in</strong>stability <strong>and</strong> the role of hMSH2<strong>in</strong> sporadic colorectalcancer. Oncogene. 1996;20;12:2641–9.16. Kim H, Jen J, Vogelste<strong>in</strong> B, Hamilton SR. Cl<strong>in</strong>ical <strong>and</strong> pathological characteristicsof sporadic colorectal carc<strong>in</strong>omas with DNA replication errors <strong>in</strong> microsatellitesequences. Am J Pathol. 1994;145:148–56.17. Chung KY, Kim NG, Li LS, Kim H, Kim H, Nam CM, Kim H, Sh<strong>in</strong> DH.Cl<strong>in</strong>icopathologic characteristics related to the high variability of cod<strong>in</strong>gmo<strong>no</strong>nucleotide repeat sequences <strong>in</strong> tumors with high-microsatellite <strong>in</strong>stability.Oncol Rep. 2003;10:439–44.18. Glebov OK, Rodriguez LM, Nakahara K, Jenk<strong>in</strong>s J, Cliatt J, Humbyrd CJ, De-Nobile J, Soballe P, Simon R, Wright G, Lynch P, Patterson S, Lynch H, Gall<strong>in</strong>gerS, Buchb<strong>in</strong>der A, Gordon G, Hawk E, Kirsch IR. Dist<strong>in</strong>guish<strong>in</strong>g rightfrom left colon by the pattern of gene expression. Cancer Epidemiol BiomarkersPrev. 2003;12:755–62.19. Bufill JA. Colorectal cancer: evidence for dist<strong>in</strong>ct <strong>genetic</strong> categories based onproximal or distal tumor location. Ann Intern Med. 1990;113:779–88.20. Pocard M, Salmon RJ, Muleris M, Remvikos Y, Bara J, Dutrillaux B, PouponMF. Deux colons—deux cancers? Ade<strong>no</strong>carc<strong>in</strong>omes coliques proximal ou distal:arguments en faveur d'une cancerogenese dist<strong>in</strong>cte [Two colons--two cancers?Proximal or distal ade<strong>no</strong>carc<strong>in</strong>oma: arguments for a different carc<strong>in</strong>ogenesis].Bull Cancer. 1995;82:10–21.21. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Bayl<strong>in</strong> SB, Issa JP. CpG isl<strong>and</strong>methylator phe<strong>no</strong>type <strong>in</strong> colorectal cancer. Proc Natl Acad Sci U S A.1999;96:8681–6.243
- Page 1 and 2:
Novel genetic and epigenetic altera
- Page 3 and 4:
TABLE OF CONTENTSACKNOWLEDGEMENTS .
- Page 5 and 6:
ACKNOWLEDGEMENTSThe present work ha
- Page 7 and 8:
Prefacetechnology[3]. This new tech
- Page 10 and 11:
SummaryThe subgroup of carcinomas w
- Page 12 and 13:
Introduction“Epigenetic inheritan
- Page 14 and 15:
Introductionamino acid change it is
- Page 16 and 17:
Introductionmethylation during embr
- Page 18 and 19:
IntroductionDNA is most of the time
- Page 20 and 21:
IntroductionFigure 5. DNA methylati
- Page 22 and 23:
IntroductionFigure 6. Incidence rat
- Page 24 and 25:
IntroductionFigure 8. Tumor staging
- Page 26 and 27:
Introductioninasmuch as 80% of colo
- Page 28 and 29:
IntroductionInstabilities involved
- Page 30 and 31:
Introductionthere seems to be a fid
- Page 32 and 33:
Introductionsevere alterations are
- Page 34 and 35:
Introductionpopulation-wide screeni
- Page 36 and 37:
IntroductionFigure 12. Present and
- Page 38 and 39:
RESULTS IN BRIEFPaper Ia. “DNA hy
- Page 40 and 41:
Results in Briefinstability, and se
- Page 42 and 43:
Results in BriefUnivariate survival
- Page 44 and 45:
Discussionseveral factors, and full
- Page 46 and 47:
Discussionlow threshold, we increas
- Page 48 and 49:
DiscussionIt may seem like unnecess
- Page 50 and 51:
Discussionthan 96% DHPLC do not sta
- Page 52 and 53:
DiscussionFigure 13. Mutation detec
- Page 54 and 55:
DiscussionClinical impact of molecu
- Page 56 and 57:
Discussionmarkers with a very high
- Page 58 and 59:
Discussionchromosomes in metaphase[
- Page 60 and 61:
DiscussionThese examples underline
- Page 62 and 63:
Discussiongenes. One is based on mu
- Page 64 and 65:
CONCLUSIONSWe have identified novel
- Page 66 and 67:
Future PerspectivesMolecular risk a
- Page 68 and 69:
REFERENCES1. Breasted J (1930) The
- Page 70 and 71:
References29. Deng G, Chen A, Pong
- Page 72 and 73:
References57. Al-Sukhni W, Aronson
- Page 74 and 75:
References84. Kunkel TA (1993) Nucl
- Page 76 and 77:
ReferencesLeggett B, Levine J, Kim
- Page 78 and 79:
References133. Lind GE, Thorstensen
- Page 80 and 81:
References156. Meling GI, Lothe RA,
- Page 82 and 83:
ReferencesT, Song X, Day RH, Sledzi
- Page 84 and 85:
References196. Honda S, Haruta M, S
- Page 86 and 87:
ORIGINAL ARTICLESAPPENDIXAppendix I
- Page 89 and 90:
GASTROENTEROLOGY 2007;132:1631-1639
- Page 91:
Paper IbGuro E Lind, Terje Ahlquist
- Page 94 and 95:
Journal of Translational Medicine 2
- Page 96 and 97:
Journal of Translational Medicine 2
- Page 98 and 99:
Journal of Translational Medicine 2
- Page 100 and 101:
Journal of Translational Medicine 2
- Page 102 and 103:
Journal of Translational Medicine 2
- Page 105:
Paper IITerje Ahlquist, Guro E Lind
- Page 108 and 109:
BackgroundMost cases of colorectal
- Page 110 and 111:
ADAMTS1 CDKN2A CRABP1 HOXA9 MAL MGM
- Page 112 and 113:
pseudogene, leading to a high rate
- Page 114 and 115:
strands. Proc Natl Acad Sci U S A 1
- Page 116 and 117:
concomitant absence of transcript a
- Page 119 and 120:
Volume 10 Number 7 July 2008 pp. 68
- Page 121 and 122:
682 RAS Signaling in Colorectal Car
- Page 123 and 124:
684 RAS Signaling in Colorectal Car
- Page 125 and 126: 686 RAS Signaling in Colorectal Car
- Page 127: Table W2. Detailed Somatic Events o
- Page 131 and 132: Identification of RCC2 as a prognos
- Page 133 and 134: INTRODUCTIONMicrosatellite instabil
- Page 135 and 136: unselected series of primary tumors
- Page 137 and 138: specificity, i.e. that they only am
- Page 139 and 140: On the assumption that DNA repair a
- Page 141 and 142: In order to ensure that gene mutati
- Page 143 and 144: Figure 2. Mutation frequency differ
- Page 145 and 146: and TAF1B (0.50), ACVR2A and ASTE1
- Page 147 and 148: Multivariate analysesA multivariate
- Page 149 and 150: When comparing our findings of muta
- Page 151 and 152: The test series included a low numb
- Page 153 and 154: entering M-phase remains to be seen
- Page 155 and 156: 12. Duval A, Reperant M, Hamelin R
- Page 157 and 158: 34. Martineau-Thuillier S, Andreass
- Page 159: AppendicesAppendix I:List of abbrev
- Page 163 and 164: Critical Reviews TM in Oncogenesis,
- Page 165 and 166: TARGET GENES OF MSI COLORECTAL CANC
- Page 167 and 168: TARGET GENES OF MSI COLORECTAL CANC
- Page 169 and 170: TARGET GENES OF MSI COLORECTAL CANC
- Page 171 and 172: TARGET GENES OF MSI COLORECTAL CANC
- Page 173 and 174: TARGET GENES OF MSI COLORECTAL CANC
- Page 175: TARGET GENES OF MSI COLORECTAL CANC
- Page 179 and 180: TARGET GENES OF MSI COLORECTAL CANC
- Page 181 and 182: TARGET GENES OF MSI COLORECTAL CANC
- Page 183 and 184: TARGET GENES OF MSI COLORECTAL CANC
- Page 185 and 186: TARGET GENES OF MSI COLORECTAL CANC
- Page 187 and 188: TARGET GENES OF MSI COLORECTAL CANC
- Page 189 and 190: TARGET GENES OF MSI COLORECTAL CANC
- Page 191: TARGET GENES OF MSI COLORECTAL CANC